ClinicalTrials.govpublic full text
Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)
primary central nervous system lymphoma, central nervous system lymphoma, pembrolizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857700
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.